Latest News - Alcon

Tuesday, May 16, 2017 | Product Releases, Alcon

Alcon Introduces SYSTANE ICAPS Chewable Eye Vitamin, the First Chewable AREDS2 Formula in the United States

Alcon announced the introduction of SYSTANE ICAPS Chewable AREDS2 eye vitamin in the US market to support eye health in people with intermediate to advanced age-related macular degeneration (AMD).…

Read the full story

Friday, May 05, 2017 | Management/Leadership, Alcon

Stephen S. Lane, MD, Joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy

Alcon has appointed Stephen S. Lane, MD, as Chief Medical Officer and Global Head Franchise Clinical Strategy. He will join the company on June 1. In his new role, Dr. Lane will lead the integratio…

Read the full story

Friday, May 05, 2017 | Product Releases, Alcon

Alcon Introduces Two New Cataract Surgical Technologies at ASCRS

Alcon launched new phaco and femtosecond laser technology innovations at the American Society of Cataract and Refractive Surgery (ASCRS) 2017 annual meeting in Los Angeles. The new Intrepid Transfo…

Read the full story

Wednesday, May 03, 2017 | Conferences, Product Releases, Alcon

Alcon Launches Newly Approved Multifocal Toric IOL with Activefocus, Highlights Other Surgical Innovations at ASCRS

Alcon will launch its AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus optical design at the American Society of Cataract and Refractive Surgery (ASCRS) 2017 annual meeting, taking place M…

Read the full story

Thursday, April 27, 2017 | Product Releases, Alcon

Alcon Launches Two Vitreoretinal Surgical Innovations at the 2017 FLOREtina Retina Meeting

Alcon has introduced the Advanced Ultravit Beveled High Speed Probe and Vektor Articulating Illuminated Laser Probe during the second edition of the FLOREtina Retina Meeting. These new technologies ar…

Read the full story

Wednesday, April 26, 2017 | Earnings & Financials, Alcon

Novartis Pushes Pipeline But Keeps An Eye On Alcon

Investors reacted well to a decent first quarter from Novartis that suggested that the long-awaited turnaround in its Alcon eyecare division has begun. While there is still investment needed, especial…

Read the full story

Thursday, March 23, 2017 | FDA Approval/Clearance, Alcon

Alcon Receives FDA Approval for AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus

Alcon has received approval from the FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus, which is designed to address astigmatism and presbyopia at the same time. The unique opti…

Read the full story

Monday, March 06, 2017 | Product Releases, Alcon

Alcon Launches New Digital Vision Care Marketing Portal for Eye Care Professionals


Alcon announced the launch of a comprehensive marketing portal with digital resources and content to help eye care professionals (ECPs) strengthen their online outreach to patients, according to a com…

Read the full story

Friday, March 03, 2017 | Health Care, Alcon

Alcon Supports Eye Health with Charitable Giving of Nearly $73 Million in 2016 and Renews Commitment to Think About Your Eyes Campaign

Alcon directly supported eye health in 2016 with nearly 650 medical missions that served more than 480,000 patients around the world and facilitated more than 47,000 surgeries, acording to a company n…

Read the full story

Thursday, January 26, 2017 | Product Releases, Alcon

Alcon Launches New Trifocal Toric IOL for Patients with Astigmatism Undergoing Cataract Surgery

Alcon announced the launch of AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting IOL for patients with preexisting corneal astigmatism undergoing cataract surgery. It is a new option for…

Read the full story

Wednesday, January 25, 2017 | Earnings & Financials, Alcon, Novartis

Novartis Considers Spinning Off Alcon Unit

Novartis said it is considering several options for its Alcon unit, including the possibility of separating from the eye care division. The announcement comes after Novartis reported that Alcon’…

Read the full story

Friday, December 23, 2016 | FDA Approval/Clearance, Alcon

Alcon Receives FDA Approval for AcrySof IQ ReSTOR +3.0D Multifocal Toric IOL

Alcon has received approval from the FDA for its AcrySof IQ ReSTOR +3.0D Multifocal Toric IOL. The new IOL is designed to address presbyopia and pre-existing corneal astigmatism at the time of ca…

Read the full story

Friday, December 16, 2016 | Partnerships, Alcon

Alcon and Right to Sight Partner to Provide Free Cataract Surgery

Alcon is partnering with the non-profit organization, Right to Sight, to provide free cataract treatment to approximately 500 community members to restore their vision and enhance their quality of lif…

Read the full story

Wednesday, November 23, 2016 | Miscellaneous, Alcon

Alcon to Host Local Multifocal Contact Lens Fitting Event for Eye Care Professionals

Alcon will host a training event in Memphis, Tennessee later this month to help eye care professionals better fit multifocal contact lenses. This event will provide eye care professionals with tips an…

Read the full story

Monday, November 21, 2016 | Miscellaneous, Alcon, Novartis

Novartis Backs Off From 2016 Date for Testing Google Autofocus Lens

Novartis has abandoned a 2016 goal to start testing its autofocus contact lens on people, though it said the groundbreaking product it is making with internet giant Google is "progressing steadil…

Read the full story
Load More